Breaking News

Karolinska Adds Mayo Pact

February 4, 2013

Aims to identify commercialization opportunities

Karolinska Development AB has entered into an agreement with Mayo Clinic to evaluate and identify commercialization opportunities in Mayo’s life science innovations to improve patient care. Both companies will be able to further invest in commercially interesting innovations, jointly or independently.
 
Torbjörn Bjerke, chief executive officer of Karolinska Development, said, "Karolinska Development invests in world-class innovations, currently from the best Nordic institutions. Mayo Clinic is one of the finest medical institutions; it is a globally recognized powerhouse of patient treatment and life sciences innovation, similar to the Karolinska Institutet. Through this agreement, Karolinska Development will not only gain access to an additional continuous flow of new ideas and projects, but we will also be able to showcase our own innovations for an excellent investor in life science.”
 
James Rogers, chair of the Mayo Clinic Venture, said, "We are pleased to announce our collaboration with Karolinska Development to identify, develop, and commercialize the new ideas being generated by Mayo physicians and scientists. Karolinska Development has a demonstrated ability to develop early stage ideas into clinically tested products for the benefit of patient care.  We are looking forward to working together on advancing innovative technologies to a commercial and clinical endpoint."
 
 

blog comments powered by Disqus
  • Newsmakers: PCI

    Newsmakers: PCI

    Tim Wright, Editor||June 2, 2015
    PCI execs talk about the recent opening of the company’s new North American clinical facility, as well as other trends in the market

  • How Sterilization of Primary Packaging Influences the Results of E&L Studies

    How Sterilization of Primary Packaging Influences the Results of E&L Studies

    Thorsten Sogding, Daniel Canton, Daniel Haines, Uwe Rothhaar, SCHOTT Pharma Services ||June 2, 2015
    As the demands that are being placed on the quality and stability of medications continue to increase, the interactions that take place between the primary packaging container and filled drug product are becoming increasingly important

  • Moore’s Law for More Health

    Moore’s Law for More Health

    Patrick Jordan , Encore Health Resources||June 2, 2015
    This year marks the semicentennial anniversary of a prediction about exponential growth and productivity